3-amino-6-methyl-5-phenyl-2(1h)-pyridinone has been researched along with indolidan in 1 studies
| Studies (3-amino-6-methyl-5-phenyl-2(1h)-pyridinone) | Trials (3-amino-6-methyl-5-phenyl-2(1h)-pyridinone) | Recent Studies (post-2010) (3-amino-6-methyl-5-phenyl-2(1h)-pyridinone) | Studies (indolidan) | Trials (indolidan) | Recent Studies (post-2010) (indolidan) |
|---|---|---|---|---|---|
| 11 | 0 | 0 | 25 | 1 | 0 |
| Protein | Taxonomy | 3-amino-6-methyl-5-phenyl-2(1h)-pyridinone (IC50) | indolidan (IC50) |
|---|---|---|---|
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | Homo sapiens (human) | 0.15 | |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B | Homo sapiens (human) | 0.15 | |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4C | Homo sapiens (human) | 0.15 | |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Homo sapiens (human) | 0.15 | |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Homo sapiens (human) | 3.54 | |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase A | Homo sapiens (human) | 3.54 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Forest, MC; Lahouratate, P; Martin, M; Nadler, G; Quiniou, MJ; Zimmermann, RG | 1 |
1 other study(ies) available for 3-amino-6-methyl-5-phenyl-2(1h)-pyridinone and indolidan
| Article | Year |
|---|---|
A novel class of cardiotonic agents: synthesis and biological evaluation of 5-substituted 3,6-dihydrothiadiazin-2-ones with cyclic AMP phosphodiesterase inhibiting and myofibrillar calcium sensitizing properties.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Calcium; Cardiotonic Agents; Dogs; Female; Guinea Pigs; Heart; Indoles; Male; Myocardial Contraction; Myocardium; Phosphodiesterase Inhibitors; Structure-Activity Relationship; Thiadiazines | 1992 |